Nurix Therapeutics Stock (NASDAQ: NRIX) stock price, news, charts, stock research, profile.
You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.
Other companies in Nurix Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and Replimune Group (NASDAQ:REPL).
Nurix Therapeutics has a consensus price target of $30.89.
The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $17.59 last updated February 14, 2025 at 4:52 PM EST.
There are no upcoming dividends for Nurix Therapeutics.
Nurix Therapeutics’s Q1 earnings are confirmed for Wednesday, April 9, 2025.
There is no upcoming split for Nurix Therapeutics.
Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.